Arcelik announced sale of 60% stake in Arcelik Hitachi to Hitachi Global Life Solutions for $205 million cash and $56 million deferred.
The deal transfers 12 subsidiaries, including manufacturing plants and R&D centers located in China and Thailand.
Arcelik shares rose about 2.3% on the news, reflecting market optimism over the strategic divestiture.
The transaction gives Hitachi Global Life Solutions majority control of the joint venture.